DNA gyrase mutations in quinolone-resistant clinical isolates of Neisseria gonorrhoeae. 1995

T Deguchi, and M Yasuda, and M Asano, and K Tada, and H Iwata, and H Komeda, and T Ezaki, and I Saito, and Y Kawada
Department of Urology, Gifu University, Japan.

Eight quinolone-resistant clinical isolates of Neisseria gonorrhoeae were shown to carry mutations in their GyrA proteins. Six isolates had a single amino acid change of serine to phenylalanine at the position corresponding to Ser-83 in Escherichia coli. In addition to the change of serine to phenylalanine, two isolates had another change of aspartic acid to asparagine at the position corresponding to Asp-87 in E. coli.

UI MeSH Term Description Entries
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D009344 Neisseria gonorrhoeae A species of gram-negative, aerobic bacteria primarily found in purulent venereal discharges. It is the causative agent of GONORRHEA. Diplococcus gonorrhoeae,Gonococcus,Gonococcus neisseri,Merismopedia gonorrhoeae,Micrococcus der gonorrhoe,Micrococcus gonococcus,Micrococcus gonorrhoeae
D004250 DNA Topoisomerases, Type II DNA TOPOISOMERASES that catalyze ATP-dependent breakage of both strands of DNA, passage of the unbroken strands through the breaks, and rejoining of the broken strands. These enzymes bring about relaxation of the supercoiled DNA and resolution of a knotted circular DNA duplex. DNA Topoisomerase (ATP-Hydrolysing),DNA Topoisomerase II,DNA Topoisomerase II alpha,DNA Topoisomerase II beta,DNA Type 2 Topoisomerase,TOP2A Protein,TOP2B Protein,Topoisomerase II,Topoisomerase II alpha,Topoisomerase II beta,Type II DNA Topoisomerase,alpha, Topoisomerase II,beta, Topoisomerase II
D004352 Drug Resistance, Microbial The ability of microorganisms, especially bacteria, to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS). Antibiotic Resistance,Antibiotic Resistance, Microbial,Antimicrobial Resistance, Drug,Antimicrobial Drug Resistance,Antimicrobial Drug Resistances,Antimicrobial Resistances, Drug,Drug Antimicrobial Resistance,Drug Antimicrobial Resistances,Drug Resistances, Microbial,Resistance, Antibiotic,Resistance, Drug Antimicrobial,Resistances, Drug Antimicrobial
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein
D000890 Anti-Infective Agents Substances that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection. Anti-Infective Agent,Anti-Microbial Agent,Antimicrobial Agent,Microbicide,Microbicides,Anti-Microbial Agents,Antiinfective Agents,Antimicrobial Agents,Agent, Anti-Infective,Agent, Anti-Microbial,Agent, Antimicrobial,Agents, Anti-Infective,Agents, Anti-Microbial,Agents, Antiinfective,Agents, Antimicrobial,Anti Infective Agent,Anti Infective Agents,Anti Microbial Agent,Anti Microbial Agents
D001483 Base Sequence The sequence of PURINES and PYRIMIDINES in nucleic acids and polynucleotides. It is also called nucleotide sequence. DNA Sequence,Nucleotide Sequence,RNA Sequence,DNA Sequences,Base Sequences,Nucleotide Sequences,RNA Sequences,Sequence, Base,Sequence, DNA,Sequence, Nucleotide,Sequence, RNA,Sequences, Base,Sequences, DNA,Sequences, Nucleotide,Sequences, RNA
D024841 Fluoroquinolones A group of QUINOLONES with at least one fluorine atom and a piperazinyl group. Fluoroquinolone
D027081 DNA Gyrase A bacterial DNA topoisomerase II that catalyzes ATP-dependent breakage of both strands of DNA, passage of the unbroken strands through the breaks, and rejoining of the broken strands. Gyrase binds to DNA as a heterotetramer consisting of two A and two B subunits. In the presence of ATP, gyrase is able to convert the relaxed circular DNA duplex into a superhelix. In the absence of ATP, supercoiled DNA is relaxed by DNA gyrase. DNA Gyrase A Subunit,DNA Gyrase B Subunit,DNA-Gyrase,GyrA Protein,GyrB Protein

Related Publications

T Deguchi, and M Yasuda, and M Asano, and K Tada, and H Iwata, and H Komeda, and T Ezaki, and I Saito, and Y Kawada
August 1996, Genitourinary medicine,
T Deguchi, and M Yasuda, and M Asano, and K Tada, and H Iwata, and H Komeda, and T Ezaki, and I Saito, and Y Kawada
May 1995, Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases,
T Deguchi, and M Yasuda, and M Asano, and K Tada, and H Iwata, and H Komeda, and T Ezaki, and I Saito, and Y Kawada
April 1996, Antimicrobial agents and chemotherapy,
T Deguchi, and M Yasuda, and M Asano, and K Tada, and H Iwata, and H Komeda, and T Ezaki, and I Saito, and Y Kawada
September 1995, Antimicrobial agents and chemotherapy,
T Deguchi, and M Yasuda, and M Asano, and K Tada, and H Iwata, and H Komeda, and T Ezaki, and I Saito, and Y Kawada
December 2005, International journal of STD & AIDS,
T Deguchi, and M Yasuda, and M Asano, and K Tada, and H Iwata, and H Komeda, and T Ezaki, and I Saito, and Y Kawada
December 2012, International journal of antimicrobial agents,
T Deguchi, and M Yasuda, and M Asano, and K Tada, and H Iwata, and H Komeda, and T Ezaki, and I Saito, and Y Kawada
December 2011, Journal of clinical microbiology,
T Deguchi, and M Yasuda, and M Asano, and K Tada, and H Iwata, and H Komeda, and T Ezaki, and I Saito, and Y Kawada
June 1996, Journal of clinical microbiology,
T Deguchi, and M Yasuda, and M Asano, and K Tada, and H Iwata, and H Komeda, and T Ezaki, and I Saito, and Y Kawada
January 1996, Sexually transmitted diseases,
T Deguchi, and M Yasuda, and M Asano, and K Tada, and H Iwata, and H Komeda, and T Ezaki, and I Saito, and Y Kawada
October 1999, Fukuoka igaku zasshi = Hukuoka acta medica,
Copied contents to your clipboard!